Oxidative damage and metabolic dysfunction in experimental Huntington's disease: selective vulnerability of the striatum and hippocampus
Maksimović, I.D.; Jovanović, M.D.; Colić, M.; Mihajlović, R.; Mićić, D.; Selaković, V.; Ninković, M.; Malicević, Z.; Rusić-Stojiljković, M.; Jovicić, A.
Vojnosanitetski Pregled 58(3): 237-242
2001
ISSN/ISBN: 0042-8450 PMID: 11548546 Document Number: 526832
Document emailed within 1 workday
Related Documents
Folstein, S.; Abbott, M.; Moser, R.; Parhad, I.; Clark, A.; Folstein, M. 1981: A phenocopy of Huntington's disease: lacunar infarcts of the corpus striatum Johns Hopkins Medical Journal 148(3): 104-108Centonze, D.; Giacomini, P.; Tolu, M.; Bernardi, G.; Calabresi, P. 2000: Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease Functional Neurology 15(4): 253-258
Hannan, A.J. 2004: Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease Acta Biochimica Polonica 51(2): 415-430
Rayssiguier, Y.; Durlach, J.; Gueux, E.; Rock, E.; Mazur, A. 1993: Magnesium and ageing. I. Experimental data: importance of oxidative damage Magnesium Research 6(4): 369-378
Nukina, N. 1999: The function of Huntington disease gene product (huntingtin) and the pathomechanism of Huntington disease Nihon Rinsho. Japanese Journal of Clinical Medicine 57(4): 905-911
Tomaszewski, A.; Kleinrok, A.; Zaczkiewicz, A.; Górny, D.; Billewicz-Stankiewicz, J. 1983: The influence of strychnine and glycine on the metabolism of acetylcholine in the rat striatum and hippocampus Polish Journal of Pharmacology and Pharmacy 35(4): 271-277
Cornett, C.R.; Markesbery, W.R.; Ehmann, W.D. 1998: Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain Neurotoxicology 19(3): 339-345
Bocca, B.; Forte, G.; Petrucci, F.; Pino, A.; Marchione, F.; Bomboi, G.; Senofonte, O.; Giubilei, F.; Alimonti, A. 2005: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease Annali Dell'istituto Superiore di Sanita 41(2): 197-203
Durkin, T.P.; Hashem-Zadeh, H.; Mandel, P.; Ebel, A. 1982: A comparative study of the acute effects of ethanol on the cholinergic system in hippocampus and striatum of inbred mouse strains Journal of Pharmacology and Experimental Therapeutics 220(1): 203-208
Korpela, H. 1990: Hepatic selenium concentration in pigs with microangiopathy (mulberry heart disease)--an animal model for the study of oxidative damage International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 60(2): 156-158
Piyabhan, P.; Wetchateng, T. 2014: Neuroprotective effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDAR1 immunodensity in the prefrontal cortex, striatum and hippocampus of sub-chronic phencyclidine rat model of schizophrenia Journal of the Medical Association of Thailand 97(Suppl 8): S50-S55
Piyabhan, P.; Wetchateng, T. 2013: Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and VGLUT1 density in the prefrontal cortex, striatum, and hippocampus of sub-chronic phencyclidine rat model of schizophrenia Journal of the Medical Association of Thailand 96(5): 625-632
Ochodnicky, P.; Vettoretti, S.; Henning, R.H.; Buikema, H.; Van Dokkum, R.P.E.; de Zeeuw, D. 2006: Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response Journal of Nephrology 19(3): 246-258
Meller, S.M.; Stilp, E.; Walker, C.N.; Mena-Hurtado, C. 2013: The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy Journal of Invasive Cardiology 25(6): 313-319
Wetchateng, T.; Piyabhan, P. 2015: Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and neuronal density in the prefrontal cortex, striatum and hippocampus in sub-chronic phencyclidine administration rat model of schizophrenia Journal of the Medical Association of Thailand 98(Suppl 2): S56-S63
Insarova, N.G.; Korshunova, T.S.; Mzhel'skaia, T.I.; Borisova, T.V. 1978: Metabolic disorders in Huntington's chorea Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 78(4): 489-495
Zhang, C.; Liu, J.; Pan, H.; Yang, X.; Bian, K. 2011: Mitochondrial dysfunction induced by excessive ROS/RNS-metabolic cardiovascular disease and traditional Chinese medicines intervention Zhongguo Zhong Yao Za Zhi 36(17): 2423-2428
Meltzer, H.Y.; Goode, D.J.; Arora, R.C. 1979: Neuromuscular dysfunction and vulnerability to psychosis Psychopharmacology Bulletin 15(1): 43-44
Jespersen, J.; Munkvad, S.; Gram, J.B. 1993: The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intima Danish Medical Bulletin 40(4): 495-502
Panina, E.B.; Botvinnik, V.S. 1992: The role of autonomic dysfunction in the pathogenesis of lipid and lipoprotein metabolic disorders in patients with metabolic-alimentary obesity Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(5-12): 22-24